The brazenness of Vivek Ramaswamy in the Republican debate caused a stir. He followed suit in biotech.

The youngest candidate on the debate stage on Wednesday night alienated his fellow Republican presidential contenders by casting doubt on their morals.

-MyNibandh

Large Radish

ridiculing their claims and implying that he was best prepared to resolve a country's issues due to his lack of political experience.

-MyNibandh

Large Radish

Ramaswamy brought a similar brazenness to biotech long before he was explaining Perestroika to Mike Pence and wishing Nikki Haley well in her future job in the defense sector. 

-MyNibandh

Large Radish

He was a 29-year-old hedge fund manager who had just graduated from Yale Law School when he began lecturing the trillion-dollar pharmaceutical industry in 2015 about how it was conducting business with regard to drug development.

-MyNibandh

Large Radish

By seeing the hidden value in medications that Pfizers and Mercks of the world were too bureaucratically blind to understand for themselves, his business, Roivant, would outsmart them.

-MyNibandh

Large Radish

In the process, he created "the highest return on investment endeavor ever taken up in the pharmaceutical industry," he said at the time to Forbes.

-MyNibandh

Large Radish

Ramaswamy demonstrated that he was divisive, as seen by the wild shouts and thunderous booing he received at the discussion on Wednesday. Some of his biotech coworkers lauded him early on as a visionary, an outsider shaking up a field that had become sclerotic at its top levels.

-MyNibandh

Large Radish

Others saw a profiteer taking advantage of the historic biotech boom at the time, a speculator with a business strategy that was more likely to make him and his hedge fund buddies wealthy than to provide any breakthrough medications.

-MyNibandh

Large Radish